Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-18 to 2023-04-18
Current total value of award: $1826.82
Description: 4560625184!LORAZEPAM INJECTION